Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

Siblings with signs of virilization should be tested for non-classical congenital adrenal hyperplasia, which does not affect adult height but may impact fertility and well-being if untreated.

Diagnose and manage hair issues in women by checking medical conditions and using personalized treatments.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

A 72-year-old man with sudden taste issues and hair growth was diagnosed with a severe stomach cancer and died within 5 months.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Some breast cancer chemotherapy can cause permanent hair loss.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

Imaging helps detect adrenal gland issues and monitor treatment in congenital adrenal hyperplasia, and can identify tumors affecting fertility.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

A man fainted and felt unwell after using a strong hair growth product, but got better when he stopped using it.

Terbinafine can cause hair loss.

Cyclosporin doesn't stop hair loss.

Finasteride improves hair loss in women with hyperandrogenism.

Skin symptoms can indicate endocrine disorders and have various treatments.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Cantú syndrome may be linked to pituitary adenomas.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

The report suggests that hair loss in Cronkhite-Canada syndrome may be caused by alopecia areata incognita, as shown by a patient's improvement with treatment.

The document says that hirsutism in women usually needs hair removal and hormone treatment to manage symptoms and improve well-being.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.